Wnt and PI3K/Akt/mTOR Survival Pathways as Therapeutic Targets in Glioblastoma.

Wnt and PI3K/Akt/mTOR Survival Pathways as Therapeutic Targets in Glioblastoma.
复制标题

DOI:
10.3390/ijms23031353
复制
发表时间:
2022-01-25
影响因子:
5.6
通讯作者:
Ghavami S
Ghavami S
中科院分区:
生物学2区
文献类型:
--
作者:
Barzegar Behrooz A;Talaie Z;Jusheghani F;Łos MJ;Klonisch T;Ghavami S

文献摘要

参考文献

被引文献

相似文献

胶质母细胞瘤(GBM)是一种毁灭性的脑肿瘤,目前的治疗方法,包括手术、化疗和放疗,最多只能起到缓解作用。设计治疗GBM的有效和靶向化疗策略需要对特定的信号通路进行彻底的分析,以确定那些作为GBM进展和侵袭的驱动因素。Wnt/β-catenin和PI3K/Akt/mTOR (PAM)信号通路是细胞增殖、上皮-间质转化(EMT)、代谢和血管生成等重要生物学功能的关键调控因子。靶向Wnt/β-catenin和PAM通路的特定调控成分有可能破坏关键的脑肿瘤细胞功能,从而在GBM替代治疗策略中取得关键进展,从而提高GBM患者的生存率。在这篇综述中,我们强调Wnt/β-catenin和PAM通路在GBM侵入脑组织中的重要性,并探讨它们作为治疗靶点的潜力。
Glioblastoma (GBM) is a devastating type of brain tumor, and current therapeutic treatments, including surgery, chemotherapy, and radiation, are palliative at best. The design of effective and targeted chemotherapeutic strategies for the treatment of GBM require a thorough analysis of specific signaling pathways to identify those serving as drivers of GBM progression and invasion. The Wnt/β-catenin and PI3K/Akt/mTOR (PAM) signaling pathways are key regulators of important biological functions that include cell proliferation, epithelial–mesenchymal transition (EMT), metabolism, and angiogenesis. Targeting specific regulatory components of the Wnt/β-catenin and PAM pathways has the potential to disrupt critical brain tumor cell functions to achieve critical advancements in alternative GBM treatment strategies to enhance the survival rate of GBM patients. In this review, we emphasize the importance of the Wnt/β-catenin and PAM pathways for GBM invasion into brain tissue and explore their potential as therapeutic targets.
DOI: 10.1158/1541-7786.mcr-14-0106-t
发表时间: 2014-11
期刊: Molecular cancer research : MCR
影响因子: --
作者:
Abbadi S;Rodarte JJ;Abutaleb A;Lavell E;Smith CL;Ruff W;Schiller J;Olivi A;Levchenko A;Guerrero-Cazares H;Quinones-Hinojosa A
通讯作者: Quinones-Hinojosa A
DOI: 10.1038/s41598-019-47021-x
发表时间: 2019-07-19
期刊: SCIENTIFIC REPORTS
影响因子: 4.6
作者:
Batsios, Georgios;Viswanath, Pavithra;Ronen, Sabrina M.
通讯作者: Ronen, Sabrina M.
DOI: 10.1021/ml200156t
发表时间: 2011-10-01
影响因子: 4.2
作者:
Burger, Matthew T.;Pecchi, Sabina;Voliva, Charles F.
通讯作者: Voliva, Charles F.
DOI: 10.1038/sj.onc.1208622
发表时间: 2005-06-16
期刊: ONCOGENE
影响因子: 8
作者:
Buzzai, M;Bauer, DE;Thompson, CB
通讯作者: Thompson, CB
DOI: 10.1038/87904
发表时间: 2001-05-01
期刊: NATURE MEDICINE
影响因子: 82.9
作者:
Carmeliet, P;Moons, L;Persico, MG
通讯作者: Persico, MG